These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation. Struyk AF; Scoggan KA; Bulman DE; Cannon SC J Neurosci; 2000 Dec; 20(23):8610-7. PubMed ID: 11102465 [TBL] [Abstract][Full Text] [Related]
7. Disrupted coupling of gating charge displacement to Na+ current activation for DIIS4 mutations in hypokalemic periodic paralysis. Mi W; Rybalchenko V; Cannon SC J Gen Physiol; 2014 Aug; 144(2):137-45. PubMed ID: 25024265 [TBL] [Abstract][Full Text] [Related]
8. Gating pore currents occur in CaV1.1 domain III mutants associated with HypoPP. Wu F; Quinonez M; Cannon SC J Gen Physiol; 2021 Nov; 153(11):. PubMed ID: 34463712 [TBL] [Abstract][Full Text] [Related]
9. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Jurkat-Rott K; Mitrovic N; Hang C; Kouzmekine A; Iaizzo P; Herzog J; Lerche H; Nicole S; Vale-Santos J; Chauveau D; Fontaine B; Lehmann-Horn F Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9549-54. PubMed ID: 10944223 [TBL] [Abstract][Full Text] [Related]
10. Stac3 enhances expression of human Ca Wu F; Quinonez M; DiFranco M; Cannon SC J Gen Physiol; 2018 Mar; 150(3):475-489. PubMed ID: 29386226 [TBL] [Abstract][Full Text] [Related]
11. Gating pore currents in DIIS4 mutations of NaV1.4 associated with periodic paralysis: saturation of ion flux and implications for disease pathogenesis. Struyk AF; Markin VS; Francis D; Cannon SC J Gen Physiol; 2008 Oct; 132(4):447-64. PubMed ID: 18824591 [TBL] [Abstract][Full Text] [Related]
12. A Na+ channel mutation linked to hypokalemic periodic paralysis exposes a proton-selective gating pore. Struyk AF; Cannon SC J Gen Physiol; 2007 Jul; 130(1):11-20. PubMed ID: 17591984 [TBL] [Abstract][Full Text] [Related]
13. Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes. Brugnoni R; Canioni E; Filosto M; Pini A; Tonin P; Rossi T; Canavese C; Eoli M; Siciliano G; Lauria G; Mantegazza R; Maggi L Neurogenetics; 2022 Jan; 23(1):19-25. PubMed ID: 34608571 [TBL] [Abstract][Full Text] [Related]
14. Transient compartment-like syndrome and normokalaemic periodic paralysis due to a Ca(v)1.1 mutation. Fan C; Lehmann-Horn F; Weber MA; Bednarz M; Groome JR; Jonsson MK; Jurkat-Rott K Brain; 2013 Dec; 136(Pt 12):3775-86. PubMed ID: 24240197 [TBL] [Abstract][Full Text] [Related]
18. Retigabine suppresses loss of force in mouse models of hypokalaemic periodic paralysis. Quiñonez M; DiFranco M; Wu F; Cannon SC Brain; 2023 Apr; 146(4):1554-1560. PubMed ID: 36718088 [TBL] [Abstract][Full Text] [Related]
20. Early-Onset Autosomal Dominant Myopathy with Vacuolated Fibers and Tubular Aggregates but No Periodic Paralysis, in a Patient with the c.1583G>A (p.R528H) mutation in the CACNA1S Gene. Bisciglia M; Kadhim H; Lecomte S; Vandernoot I; Desmyter L; Remiche G J Neuromuscul Dis; 2024; 11(4):871-875. PubMed ID: 38788083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]